InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,736.89
(
0.42%
)
US TECH 100
19,494.80
(
0.28%
)
Dow Jones
41,853.49
(
0.14%
)
Brent Oil
75.74
(
0.83%
)
Bitcoin
69,676.57
(
2.73%
)
Post# of 253531
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: mcbio post# 114027

Thursday, 02/03/2011 10:40:42 PM

Thursday, February 03, 2011 10:40:42 PM

Post# of 253531

So, bottom line, it sounds like ponatinib could in fact have utility in colon and possibly other cancers outside of the current focus if these studies ultimately pan out and SRC/LYN are the cancer culprits.



Yes, I think that is a reasonable summary. But I doubt whether Aria on its own can properly explore these other indications.

Peter

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up